R&D How to optimise commercial-scale ATMP manufacturing through ... This is the second part of our series, "The ATMP Manufacturer's Guide to Commercialisation and cGMP Compliance".
News AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
